Crossmark

Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2018.06.007

Published Print: 2019-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Alcántara Montero, A.
License Information

Text and Data Mining valid from 2019-01-01
More Information

This article is maintained by: Elsevier

Article Title: Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2018.06.007

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2018.06.002

Content Type: simple-article

Copyright: © 2018 AEU. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below